Theriva Biologics
TOVX
TOVX
51 hedge funds and large institutions have $27.9M invested in Theriva Biologics in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less funds holding
Funds holding: 53 → 51 (-2)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Holders
51
Holding in Top 10
1
Calls
$9.75M
Puts
–
Top Buyers
| 1 | +$171K | |
| 2 | +$163K | |
| 3 | +$98.1K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$90K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$86K |
Top Sellers
| 1 | -$2.12M | |
| 2 | -$906K | |
| 3 | -$639K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$424K |
| 5 |
ECM
Element Capital Management
New York
|
-$277K |